Our Posts

Antidepressant medications, intended to improve mood, have been linked to unprovoked violence, leading to wrongful death and injury lawsuits against pharmaceutical companies. Scientific studies and legal cases suggest these drugs may cause aggressive side effects. Victims or their families may pursue legal action for compensation. Parker Waichman LLP specializes in such cases, advocating for victims' justice and holding drug manufacturers accountable. The firm offers legal representation without upfront fees, ensuring clients can seek justice without financial burden.

The FDA has warned that the Type-2 diabetes drugs Invokana and Invokamet, made by Janssen Pharmaceuticals, may lead to lower limb amputations. Initially, Janssen did not inform patients of this risk, but warnings are now included on the packaging. Legal actions are underway, with Parker Waichman LLP representing affected individuals. Invokana, approved in 2013, helps control blood sugar by aiding kidney function. Despite its benefits, serious side effects like amputations and diabetic ketoacidosis have led to lawsuits against Johnson & Johnson for inadequate warnings.

The DePuy Pinnacle hip implant, a metal-on-metal device, is facing growing concerns due to its potential to shed metal particles, leading to tissue breakdown, bone loss, and cobalt poisoning. Lawsuits have been consolidated into a multidistrict litigation (MDL) in the U.S. District Court for Northern Texas, overseen by Judge James Kinkeade. This consolidation aims to streamline pretrial proceedings. The Pinnacle device, similar to the recalled DePuy ASR system, has sold approximately 150,000 units, surpassing the ASR's 93,000.

The Stryker V40 femoral heads have prompted regulatory actions in Canada and Australia due to a high rate of taper lock failures, leading to recalls. These failures can cause severe complications such as pain, inflammation, and the need for revision surgery. The taper lock connects the femoral head to the neck, and its failure can result in adverse events like dislocation and joint instability. Stryker has faced numerous lawsuits over its metal-on-metal hip implants, with allegations of defective design and failure to warn about risks.

Litigation against 3M and Arizant Healthcare over the Bair Hugger surgical warming blanket is increasing, with a new lawsuit filed by a New York man claiming it caused a deep joint infection, necessitating further surgeries and antibiotic treatment. Over 450 similar cases are pending in Minnesota courts. Plaintiffs allege the device, used to maintain body temperature during surgery, causes infections, including MRSA, due to its forced-air design. The lawsuits accuse the companies of failing to warn about infection risks and claim the product is defectively designed. A multidistrict litigation has been established to streamline these cases.

C.R. Bard has agreed to settle most personal injury lawsuits related to the defective Composix Kugel Mesh Hernia Patch, nearly six years after the first recall by the FDA. The company will incur a $184 million charge to cover these settlements. Over 3,500 lawsuits have been filed, with more than 1,300 in federal multidistrict litigation in Rhode Island. The settlement does not include potential class action lawsuits in the U.S. and Canada. The initial recall was due to reports of the device's recoil ring breaking, causing serious injuries.

A Pennsylvania man has filed a lawsuit against DePuy Orthopaedics and Johnson & Johnson, alleging that the DePuy Pinnacle metal-on-metal hip implant is defective and caused him severe injuries. The implant reportedly releases harmful metallic ions into the body, leading to serious health issues. The plaintiff underwent costly revision surgery to remove the implant and claims the companies failed to warn the public about the risks. Many recipients of the implant experience complications within five years, despite its expected 15-year lifespan. The lawsuit highlights a history of inadequate consumer warnings by the companies.

A recent study highlighted by Reuters reveals that many medical facilities are not properly cleaning endoscopes, leading to potential cross-contamination and infections. Despite CDC guidelines for reprocessing endoscopes, many facilities fail to follow them adequately, resulting in contaminated equipment. The study found significant contamination in endoscopes, with high risks in bronchoscopes and urology scopes. The FDA has also criticized certain endoscope connectors for lacking reprocessing features, advising against their use. Experts recommend using sterilized endoscopes and conducting regular audits to ensure patient safety.

Lawyers are reviewing cases related to defective metal-on-metal hip replacements due to increasing revision rates. Studies show a rise in revision surgeries for these implants, particularly those with Pinnacle components, from 2007 to 2012. This increase is attributed to enhanced patient monitoring and earlier surgical interventions. Metal-on-metal implants have been linked to severe complications, including metallosis and tissue damage, due to metal debris. Manufacturers face criticism and lawsuits for allegedly downplaying these risks while continuing to market the devices.

A hernia occurs when an organ or fatty tissue pushes through a weak spot in a muscle or connective tissue, often in the abdominal wall. It can appear as an external bulge, especially when straining. Hernias are caused by pressure and muscle weakness, with factors like obesity, heavy lifting, and chronic coughing contributing. Surgery is the only repair option, using either laparoscopic or open repair methods, sometimes with hernia mesh. Mesh can fail, leading to severe complications. Symptoms of mesh failure include pain, infection, and hernia recurrence. Legal action may be possible for those affected by mesh complications.

Federal Judge Ed Kinkeade denied DePuy Orthopaedics' request to delay the September trial in the multidistrict litigation over Pinnacle metal-on-metal hip implants. DePuy sought the delay after a March trial awarded $500 million to plaintiffs claiming injuries from the implants. The plaintiffs reported severe complications, including pain, implant loosening, and metal poisoning. Metal-on-metal implants, initially marketed as durable, have shown high failure rates. The trial includes expert testimonies and critiques of the device approval process. Despite recalling a similar product, DePuy has not recalled the Pinnacle hips.

A jury awarded $55 million to a plaintiff who developed ovarian and endometrial cancer after using Johnson & Johnson's talcum powder for over 40 years. The Missouri 22nd Judicial Circuit Court upheld the verdict, leading J&J to appeal. The award included $5 million in compensatory and $50 million in punitive damages. Over 1,000 similar lawsuits claim J&J knew of the cancer risks associated with talcum powder but failed to warn consumers. These cases are being centralized in Missouri and New Jersey, with potential multidistrict litigation.

District Judge Ronnie L. White denied a motion to dismiss conspiracy claims against Johnson & Johnson and Imerys Talc America in a lawsuit filed by a man whose wife died of ovarian cancer, allegedly due to talcum powder use. The lawsuit claims the companies conspired to hide the dangers of talc by forming the "Talc Interested Party Task Force," releasing false safety information, and influencing regulatory bodies. The suit alleges these actions aimed to prevent consumers from learning about the potential harmful effects of talc.

The third bellwether trial in the DePuy Pinnacle hip implant litigation began with jury selection on September 19 in Dallas, Texas, overseen by U.S. District Judge Ed Kinkeade. The multidistrict litigation involves claims that the metal-on-metal design of the implants caused injuries such as implant loosening, pain, and metal poisoning. Plaintiffs allege that DePuy Orthopaedics and Johnson & Johnson failed to warn about these risks. Despite a previous $151 million award, DePuy is appealing, and approximately 8,400 lawsuits are consolidated in the MDL.

Actemra, a drug for rheumatoid arthritis, was initially marketed as having fewer severe side effects compared to other treatments. However, reports indicate that Actemra may pose significant risks, including heart attacks, strokes, and other serious conditions, which are not listed on its label. Despite these concerns, the drug remains on the market. Experts suggest that federal regulators should issue warnings about these risks. Patients and doctors may be misled about Actemra's safety due to the lack of warning labels for frequently reported side effects.

A Texas federal court has rendered a judgment in favor of DePuy Orthopaedics Inc. in a lawsuit alleging that their Pinnacle metal hip implant caused injuries. The case, filed by a Montana woman, claimed the implants led to severe pain and dangerously high levels of cobalt and chromium in her bloodstream, necessitating revision surgeries. Despite these claims, the jury found for the defendants in October 2014, concluding that the injuries were due to improper implantation rather than a defect in the device.

The Mirena IUD multidistrict litigation involves women who claim to have developed symptoms similar to brain tumors, known as pseudotumor cerebri, after using the device. These cases have been consolidated into MDL 2767 in the Southern District of New York. Plaintiffs allege that Bayer, the manufacturer, failed to warn about the risks associated with the hormone levonorgestrel in the IUD. Bayer denies these claims, arguing that other factors like obesity contribute to the condition. The litigation focuses on proving causation between the IUD and intracranial hypertension.

Parker Waichman LLP offers free consultations for potential Gadolinium Deposition Disease clients. They investigate cases with no upfront fees and work on a contingency basis, meaning they only get paid if you do. It's crucial to act quickly to preserve your rights. Contact them at 1-800-YOURLAWYER (1-800-968-7529) or fill out their consultation form to have an experienced lawyer discuss your rights and claim options.

Proton pump inhibitors (PPIs), used to treat conditions like GERD and ulcers, are being over-prescribed, leading to potential health risks. Overuse can result in dangerous side effects, including fractures, pneumonia, and infections due to altered gut acidity. The FDA has updated safety labels to warn of these risks, particularly for long-term users. Concerns are rising among healthcare providers, with many considering reducing PPI prescriptions. Alternatives, such as dietary changes, may help manage symptoms without PPIs.

Inferior vena cava (IVC) filters, used to prevent blood clots, have faced significant legal challenges due to alleged injuries and complications, including punctured veins and organ damage. Thousands of lawsuits are pending against manufacturers like Cook and Bard, with claims that the devices are prone to migration and breakage. The FDA's 510(k) rule allowed these filters to be marketed without rigorous testing. A recent verdict ordered C.R. Bard to pay nearly $4 million, potentially influencing future litigation. Victims may seek compensation for medical expenses, lost wages, and more.

Talcum baby powder, commonly used by women, has been linked to ovarian and endometrial cancers, raising safety concerns. Studies, including those by Parker Waichman LLP and the European Journal of Cancer Prevention, suggest a potential risk from genital use. Talc, historically containing asbestos, is now asbestos-free in U.S. products. The WHO classifies genital talc use as possibly carcinogenic, though the CDC does not list it as a risk factor. Legal actions against manufacturers like Johnson & Johnson highlight ongoing concerns, with alternatives like cornstarch-based products recommended.

Johnson & Johnson's DePuy Orthopaedics announced plans to discontinue certain metal-on-metal hip devices, including the Ultamet and Complete implants, due to low usage, alternative products, and upcoming regulatory changes. This decision follows nearly 11,000 lawsuits related to the recalled DePuy ASR hip implant. The company clarified that the discontinuation is not a recall and is unrelated to safety concerns. The DePuy Pinnacle system will remain available despite ongoing lawsuits. The FDA is considering stricter approval guidelines for metal hip implants to ensure safety and efficacy.

Two patients who underwent hip replacement surgeries contracted serious infections, allegedly due to the Bair Hugger warming blanket used during their procedures. This device, made by 3M, is intended to maintain patient warmth during surgery, reducing risks like bleeding and infection. However, it may inadvertently circulate contaminants, increasing infection risk. Despite 300 FDA reports of adverse reactions, 3M denies a direct link between the device and infections. The inventor, Dr. Scott Augustine, suggests a recall, citing potential dangers in joint implant surgeries. Legal assistance is available for affected individuals.

Parker Waichman LLP is investigating claims that Glyxambi, a medication for Type 2 diabetes, may lead to lower extremity amputations due to infections from its SGLT2 inhibitors. Glyxambi combines empagliflozin and linagliptin, manufactured by Boehringer Ingelheim. The law firm, based in New York, has recovered over $2 billion for clients and offers legal assistance to those affected by amputations or other complications like diabetic acidosis or kidney failure after taking Glyxambi. Patients are advised to monitor for symptoms indicating potential vascular issues.